Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
7,942,180
-
Share change
-
-44,908
-
Total reported value
-
$113,685,116
-
Price per share
-
$14.31
-
Number of holders
-
30
-
Value change
-
-$1,235,865
-
Number of buys
-
16
-
Number of sells
-
13
Institutional Holders of TCR2 THERAPEUTICS INC - COM (TCRR) as of Q2 2019
As of 30 Jun 2019,
TCR2 THERAPEUTICS INC - COM (TCRR) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,942,180 shares.
The largest 10 holders included
MPM ASSET MANAGEMENT LLC, Redmile Group, LLC, Artal Group S.A., ArrowMark Colorado Holdings LLC, HILLHOUSE CAPITAL MANAGEMENT, LTD., JPMORGAN CHASE & CO, MILLENNIUM MANAGEMENT LLC, AMERIPRISE FINANCIAL INC, BlackRock Inc., and VANGUARD GROUP INC.
This page lists
30
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.